Your browser doesn't support javascript.
loading
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes.
Januszewski, Andrzej S; Chen, David; Scott, Russell S; O'Connell, Rachel L; Aryal, Nanda R; Sullivan, David R; Watts, Gerald F; Taskinen, Marja-Riitta; Barter, Philip J; Best, James D; Simes, R John; Keech, Anthony C; Jenkins, Alicia J.
Afiliación
  • Januszewski AS; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, Sydney, NSW, 2050, Australia.
  • Chen D; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, Sydney, NSW, 2050, Australia.
  • Scott RS; Monash School of Medicine, Monash University, Melbourne, VIC, Australia.
  • O'Connell RL; Lipid and Diabetes Research Group, Christchurch Hospital, Christchurch, New Zealand.
  • Aryal NR; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, Sydney, NSW, 2050, Australia.
  • Sullivan DR; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, Sydney, NSW, 2050, Australia.
  • Watts GF; Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Taskinen MR; Faculty of Health and Medical Sciences, School of Medicine, University of Western Australia, Perth, Australia.
  • Barter PJ; Lipid Disorders Clinic, Cardiometabolic Services, Department of Cardiology, Royal Perth Hospital, Perth, Australia.
  • Best JD; Cardiovascular Research Unit, Helsinki, Heart and Lung Centre, University Central Hospital, Helsinki, Finland.
  • Simes RJ; Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland.
  • Keech AC; Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia.
  • Jenkins AJ; Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia.
Sci Rep ; 11(1): 18708, 2021 09 21.
Article en En | MEDLINE | ID: mdl-34548531
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenofibrato / Diabetes Mellitus Tipo 2 / Colorantes Fluorescentes / Hipolipemiantes Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenofibrato / Diabetes Mellitus Tipo 2 / Colorantes Fluorescentes / Hipolipemiantes Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article